Company Filing History:
Years Active: 2020
Title: Innovations of Jonathan M Shillingford
Introduction
Jonathan M Shillingford is an accomplished inventor based in West Lafayette, IN (US). He has made significant contributions to the field of biochemistry, particularly in the development of therapeutic agents targeting cancer.
Latest Patents
Shillingford holds a patent for "Carbonic anhydrase IX inhibitor conjugates and uses thereof." This patent relates to compositions and methods of carbonic anhydrase IX inhibitors. It also discusses targeting conjugates of these inhibitors as therapeutics and imaging agents. The patent emphasizes the use of these targeting conjugates in imaging methods and cancer therapy.
Career Highlights
Jonathan M Shillingford is associated with Endocyte, Inc., where he applies his expertise in developing innovative solutions for cancer treatment. His work focuses on enhancing the efficacy of cancer therapies through targeted approaches.
Collaborations
Some of his notable coworkers include Christopher Paul Leamon and Iontcho Radoslavov Vlahov. Their collaborative efforts contribute to advancing research and development in their field.
Conclusion
Jonathan M Shillingford's work exemplifies the intersection of innovation and healthcare, particularly in cancer therapy. His contributions through patents and collaborations highlight the importance of targeted treatments in modern medicine.